{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TARGET&page=47", "query": { "intervention": "TARGET", "page": 47 }, "page_size": 10 }, "pagination": { "page": 47, "page_size": 10, "total_count": 9993, "total_pages": 1000, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TARGET&page=48&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TARGET&page=46&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-05T15:56:21.089Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01356290", "title": "Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Medulloblastoma Recurrent", "Ependymoma Recurrent", "ATRT Recurrent", "Rare CNS Tumor Recurrent" ], "interventions": [ { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Thalidomide", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Fenofibric acid", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Temozolomide (TMZ)", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medical University of Vienna", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "19 Years", "sex": "ALL", "summary": "Up to 19 Years" }, "enrollment_count": 232, "start_date": "2014-04", "completion_date": "2030-04", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-11-05T15:56:21.089Z", "location_count": 4, "location_summary": "Chicago, Illinois • Boston, Massachusetts • Grand Rapids, Michigan + 1 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01356290" }, { "nct_id": "NCT00353613", "title": "Prevention of Surgical Site Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Surgical Wound Infection" ], "interventions": [ { "name": "Package of targeted interventions to reduce error", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 900, "start_date": "2007-03", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2013-06-18", "last_synced_at": "2026-11-05T15:56:21.089Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00353613" }, { "nct_id": "NCT07650240", "title": "Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Prostate Adenocarcinoma", "Stage IVB Prostate Cancer AJCC v8", "Castration-Sensitive Prostate Cancer", "Metastatic Hormone-sensitive Prostate Cancer (mHSPC)", "Prostate Cancer", "Prostate Adenocarcinoma", "Adenocarcinoma of the Prostate", "Localized Prostate Carcinoma", "Metastatic Prostate Cancer", "Metastatic Prostate Adenocarcinoma", "Advanced Prostate Cancer", "Advanced Prostate Adenocarcinoma" ], "interventions": [ { "name": "Abiraterone Acetate", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Leuprolide Acetate", "type": "DRUG" }, { "name": "Lutetium Lu 177 Vipivotide Tetraxetan", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "PSMA PET-CT Scan", "type": "PROCEDURE" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Single Photon Emission Computed Tomography", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 202, "start_date": "2026-08-04", "completion_date": "2030-12-30", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-11-05T15:56:21.089Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07650240" }, { "nct_id": "NCT05540340", "title": "A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lymphoma", "Lymphoma, B-Cell", "Lymphoma, T-Cell", "Lymphoma, Hodgkin", "Lymphoma, Non-Hodgkin" ], "interventions": [ { "name": "Pharmacokinetics", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 39, "start_date": "2022-09-09", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-11-05T15:56:21.089Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05540340" }, { "nct_id": "NCT04879368", "title": "RegoNivo vs Standard of Care Chemotherapy in AGOC", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Gastro-Oesophageal Cancer" ], "interventions": [ { "name": "Regorafenib", "type": "DRUG" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Docetaxel", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "Trifluridine/Tipracil", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Australasian Gastro-Intestinal Trials Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 462, "start_date": "2021-05-05", "completion_date": "2025-04-30", "has_results": true, "last_update_posted_date": "2026-06-10", "last_synced_at": "2026-11-05T15:56:21.089Z", "location_count": 6, "location_summary": "Scottsdale, Arizona • Los Angeles, California • Sioux City, Iowa + 3 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sioux City", "state": "Iowa" }, { "city": "Edgewood", "state": "Kentucky" }, { "city": "Rapid City", "state": "South Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04879368" }, { "nct_id": "NCT05609097", "title": "PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Failure With Reduced Ejection Fraction" ], "interventions": [ { "name": "PRIME", "type": "OTHER" }, { "name": "COMBO", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 92, "start_date": "2023-04-14", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2025-06-06", "last_synced_at": "2026-11-05T15:56:21.089Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05609097" }, { "nct_id": "NCT06906497", "title": "Lebrikizumab in Moderate-to-severe Atopic Dermatitis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "lebrikizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johann E Gudjonsson MD PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2025-07-02", "completion_date": "2028-07", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-11-05T15:56:21.089Z", "location_count": 2, "location_summary": "Folsom, California • Ann Arbor, Michigan", "locations": [ { "city": "Folsom", "state": "California" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06906497" }, { "nct_id": "NCT00127413", "title": "Integrated Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain", "Posttraumatic Stress Disorder" ], "interventions": [ { "name": "Cognitive Behavioral Therapy - Pain", "type": "BEHAVIORAL" }, { "name": "Cognitive Behavioral Therapy-Integrated", "type": "BEHAVIORAL" }, { "name": "Cognitive Processing Therapy - PTSD", "type": "BEHAVIORAL" }, { "name": "Treat as Usual", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "US Department of Veterans Affairs", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 42, "start_date": "2004-09", "completion_date": "2010-09", "has_results": true, "last_update_posted_date": "2015-03-27", "last_synced_at": "2026-11-05T15:56:21.089Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00127413" }, { "nct_id": "NCT00367224", "title": "Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vitiligo" ], "interventions": [ { "name": "6 to 9 ultraviolet B treatments", "type": "PROCEDURE" }, { "name": "Skin biopsies", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2006-01", "completion_date": "2008-05", "has_results": false, "last_update_posted_date": "2024-04-30", "last_synced_at": "2026-11-05T15:56:21.089Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00367224" }, { "nct_id": "NCT05586308", "title": "Incentive-based and Media Literacy Informed Approaches to Improve Vaping Cessation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Behavior, Health Risk", "Implementation Science", "E Cigarette Use", "Cessation, Smoking", "Incentives", "Engagement, Patient", "Peer Support", "Media Literacy" ], "interventions": [ { "name": "Text-massaging suport", "type": "BEHAVIORAL" }, { "name": "Financial incentive", "type": "BEHAVIORAL" }, { "name": "Media literacy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Nebraska", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "29 Years", "sex": "ALL", "summary": "19 Years to 29 Years" }, "enrollment_count": 40, "start_date": "2023-12-07", "completion_date": "2025-06-30", "has_results": true, "last_update_posted_date": "2026-01-29", "last_synced_at": "2026-11-05T15:56:21.089Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT05586308" } ] }